Quick Links

Research news

Understanding bone death

McGill Newsroom Researchers discover new genetic mutation linked to osteonecrosis of the hip Scientists at the Research Institute of McGill University Health Centre (RI-MUHC) have discovered a new genetic mutation linked to osteonecrosis of the hip, specifically the femoral head – the spherical-shaped mass at the top of the femur. This breakthrough could allow doctors to identify and treat the disease before symptoms arise and potentially avoid hip replacements.

Published on : 13 Jul 2016

“Big Data” study discovers earliest sign of Alzheimer’s

McGill Newsroom Research underlines importance of computational power in future neurological breakthrough Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease (LOAD), identifying its first physiological signs.

Published on : 11 Jul 2016

“Big Data” study discovers earliest sign of Alzheimer’s development

Research underlines importance of computational power in future neurological breakthrough Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer’s disease (LOAD), identifying its first physiological signs.

Published on : 11 Jul 2016

New path of discovery in Parkinson’s disease

McGill Newsroom Neuron cell death may be caused by overactive immune system  A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at McGill University have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.

Published on : 28 Jun 2016

Researchers open new path of discovery in Parkinson’s disease

A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at McGill University have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease. Using both cellular and mouse models, the team has shown that proteins produced by the two genes, known as PINK1 and Parkin, are required to prevent cells from being detected and attacked by the immune system.

Published on : 27 Jun 2016

$4 million for research on intellectual disabilities

McGill Newsroom Couche-Tard founder gives $4 million to McGill for groundbreaking research on intellectual disabilities

Published on : 22 Jun 2016

Decoding connectivity

McGill Newsroom It’s all math: How Professor Alan Evans is using cutting-edge statistics to unravel the complexity of brain disorders. When Alan Evans was starting out in the 1970s, researchers didn’t ask the boss to foot their bar tab. But that’s exactly what some of the coders in his Montreal Neurological Institute lab recently proposed: a 9-to-5 Saturday hackathon, held in an Irish pub a few blocks from the McGill University campus.

Published on : 20 Jun 2016

Creation of neuroscience research hub

McGill Newsroom EMC working with McGill to support data storage and visualization technologies to help with the NeuroHub project The Canadian research team that helped spearhead the international brain-mapping project known as BigBrain is about to get a major boost in its effort to produce sharply higher-resolution brain maps, thanks to technology from EMC Corporation.

Published on : 15 Jun 2016

The impact of night work on our immune system

McGill Newsroom Study reveals the impact of night work You cross paths with him at the break of dawn in the corridors of the Metro. He looks bleary-eyed and pallid. This worker’s night shift just ended. His body clocks are out of sync with one another, and, imperceptibly, they’re also out of sync with his environment. In the long run, this night owl could be at greater risk of developing cardiovascular, autoimmune diseases or certain types of cancer.

Published on : 14 Jun 2016

New name for McGill Department of Oncology

McGill Newsroom Newly named Gerald Bronfman Department of Oncology recognizes family’s enduring support In recognition of the Bronfman family’s enduring support for oncology programs and research at McGill University, the Faculty of Medicine’s Department of Oncology has been named the Gerald Bronfman Department of Oncology, in honour of one of the family’s major benefactors.

Published on : 13 Jun 2016

ALS Awareness Month – June 2016

The Neuro is recognized as a major Canadian center for ALS research and patient care. During June, designated ALS Month, The Neuro redoubles its efforts to inform the public and the media about amyotrophic lateral sclerosis (ALS), and urges all to help support ALS research.

Published on : 13 Jun 2016

A molecular on/off switch for antibiotic resistance

McGill Newsroom Antibiotic resistance represents a major challenge in treating pathogenic bacterial infections. Now, researchers at McGill University have discovered a possible target for fighting back against resistant bacteria.

Published on : 09 Jun 2016

$17 Million to shape the future of music

​McGill Newsroom  This significant investment of public and private support will redefine the future of music research in Canada by transforming the way musicians compose, listen and perform music.

Published on : 03 Jun 2016

Are EEG neurofeedback benefits due to placebo effects?

Neurofeedback using electroencephalograpy boasts thousands of practitioners and appears to both improve normal brain function and alleviate a wide variety of mental disorders – from anxiety to alcoholism. But after examining the scientific literature and consulting experts in Europe and the U.S., McGill University researchers Robert Thibault and Amir Raz conclude that clinical improvements from this increasingly popular alternative therapy are due to placebo effects.

Published on : 02 Jun 2016